Skip to main content

AMERIPRISE FINANCIAL INC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 820027 MINNEAPOLIS, MN

Position in XENE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,227,556
+$14,639,232 QoQ
Shares Held
318,548
+303.7% QoQ
Ownership
0.329%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 314 holders
Holding Since
Sep 2021
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. XENE ranks #35 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XENE

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,227,556 318,548
2026-03-31 $4,588,324 78,905
2025-12-31 $4,909,761 109,544
2025-09-30 $3,917,313 97,567
2025-06-30 $3,819,413 122,026
2025-03-31 $3,476,584 103,624
2024-12-31 $3,620,120 92,350
2024-09-30 $2,613,497 66,383
2022-12-31 $892,143 22,626
2022-09-30 $1,485,298 41,144
2022-06-30 $1,556,773 51,176
2022-03-31 $1,770,981 57,932
2021-12-31 $1,821,948 58,321
2021-09-30 $224,616 14,700